Keith T. Flaherty, Director at Loxo Oncology, Inc. (LOXO), sold 98,100 shares at $174.04 ($17.0M) on 2018-06-07, disclosed to the SEC on 2018-06-11.
Open-market sale of $17.0M LOXO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $169.85 | 1,900 | $323K | 1.9% |
| 2 | $171.15 | 5,021 | $859K | 5.0% |
| 3 | $171.15 | 5,021 | $859K | 5.0% |
| 4 | $172.03 | 4,634 | $797K | 4.7% |
| 5 | $172.03 | 4,634 | $797K | 4.7% |
| 6 | $173.32 | 12,243 |
| $2.1M |
| 12.5% |
| 7 | $173.32 | 12,243 | $2.1M | 12.5% |
| 8 | $174.04 | 16,037 | $2.8M | 16.4% |
| 9 | $174.04 | 16,037 | $2.8M | 16.4% |
| 10 | $175.10 | 4,743 | $830K | 4.9% |
| 11 | $175.10 | 4,743 | $830K | 4.9% |
| 12 | $175.97 | 5,422 | $954K | 5.6% |
| 13 | $175.97 | 5,422 | $954K | 5.6% |
| Total | $173.61 avg | 98,100 | $17.0M | 100% |
| Filing → |
| LOXO | SELL | 2017-05-24 | $649K | — | Filing → |
| LOXO | SELL | 2017-02-23 | $601K | — | Filing → |
| LOXO | SELL | 2016-12-21 | $438K | — | Filing → |